The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Experimental Protection of Mice against Lethal Staphylococcus aureus Infection by Novel Bacteriophage φMR11
Abstract
The protective effects of bacteriophages were assessed against experimental Staphylococcus aureus infection in mice. Of the S. aureus phages isolated in the study, phi MR11 was representatively used for all testing, because its host range was the most broad and it carries no genes for known toxins or antibiotic resistance. Intraperitoneal injections (8 x 10(8) cells) of S. aureus, including methicillin-resistant bacteria, caused bacteremia and eventual death in mice. In contrast, subsequent intraperitoneal administration of purified phi MR11 (MOI > or = 0.1) suppressed S. aureus-induced lethality. This lifesaving effect coincided with the rapid appearance of phi MR11 in the circulation, which remained at substantial levels until the bacteria were eradicated. Inoculation with high-dose phi MR11 alone produced no adverse effects attributable to the phage. These results uphold the efficacy of phage therapy against pernicious S. aureus infections in humans and suggest that phi MR11 may be a potential prototype for gene-modified, advanced therapeutic S. aureus phages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Bacteriophage lysis: mechanism and regulation
Young, R. (1992) · Microbiological Reviews · doi:10.1128/mmbr.56.3.430-481.1992 · Cited by 773
A bacteriolytic agent that detects and kills Bacillus anthracis
Schuch, R., Nelson, D., & Fischetti, V. A. (2002) · Nature · doi:10.1038/nature01026 · Cited by 656
Nelson, D., Loomis, L., & Fischetti, V. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061038398 · Cited by 578
Smith, H. W., & Huggins, M. B. (1982) · Microbiology · doi:10.1099/00221287-128-2-307 · Cited by 518
Rapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase
Loeffler, J. M., Nelson, D., & Fischetti, V. A. (2001) · Science · doi:10.1126/science.1066869 · Cited by 517
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A. N., Powell, B., Carlton, R., & Merril, C. R. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.204-210.2002 · Cited by 467
Smith, H. W., & Huggins, M. B. (1983) · Microbiology · doi:10.1099/00221287-129-8-2659 · Cited by 436
The Control of Experimental Escherichia coli Diarrhoea in Calves by Means of Bacteriophages
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1111 · Cited by 365
Phage therapy: past history and future prospects.
Carlton, R. M. (1999) · PubMed · Cited by 342
Bacteriophages show promise as antimicrobial agents
Alisky, J., Iczkowski, K., Rapoport, A., & Troitsky, N. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)92874-2 · Cited by 318
Barrow, P., Lovell, M., & Berchieri, A. (1998) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.3.294-298.1998 · Cited by 293
Understanding Bacteriophage Therapy as a Density-dependent Kinetic Process
PAYNE, R. J. H., & JANSEN, V. A. A. (2001) · Journal of Theoretical Biology · doi:10.1006/jtbi.2000.2198 · Cited by 233
Kaneko, J., Kimura, T., Narita, S., Tomita, T., & Kamio, Y. (1998) · Gene · doi:10.1016/s0378-1119(98)00278-9 · Cited by 231
Uehara, Y., Nakama, H., Agematsu, K., Uchida, M., Kawakami, Y., Abdul Fattah, A. S. M., & Maruchi, N. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.1999.0680 · Cited by 229
Treatment of experimental infections of mice with bacteriophages
SOOTHILL, J. S. (1992) · Journal of Medical Microbiology · doi:10.1099/00222615-37-4-258 · Cited by 220
Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals
Payne, R. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109520 · Cited by 216
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1127 · Cited by 202
Bacteriophage Therapy of Bacterial Infections: An Update of our Institute’s Experience
Weber-Dąbrowska, B., Mulczyk, M., & Górski, A. (2001) · Inflammation · doi:10.1007/978-94-015-9702-9_15 · Cited by 199
Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail
Nakai, T., Sugimoto, R., Park, K., Matsuoka, S., Mori, K., Nishioka, T., & Maruyama, K. (1999) · Diseases of Aquatic Organisms · doi:10.3354/dao037033 · Cited by 198
Fate of Bacteriophage Lambda in Non-immune Germ-free Mice
GEIER, M. R., TRIGG, M. E., & MERRIL, C. R. (1973) · Nature · doi:10.1038/246221a0 · Cited by 191
Levin, B. R., & Bull, J. J. (1996) · The American Naturalist · doi:10.1086/285884 · Cited by 159
Microbiology and Microbial Infections
Esch, G. W., Collier, L., Balows, A., & Sussman, M. (1998) · Journal of Parasitology · doi:10.2307/3284576 · Cited by 148
Félix d`Herelle and the Origins of Molecular Biology
Summers, W. C. (1999) · Cited by 138
Phage therapy—advantages over antibiotics?
Pirisi, A. (2000) · The Lancet · doi:10.1016/s0140-6736(05)74059-9 · Cited by 109
Kaneko, J., Kimura, T., Kawakami, Y., Tomita, N., & Kamio, Y. (1997) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.61.1960 · Cited by 88
Inoue, T., Matsuzaki, S., & Tanaka, S. (1995) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1995.tb07342.x · Cited by 58
Self-citationUehara, Y., Kikuchi, K., Nakamura, T., Nakama, H., Agematsu, K., Kawakami, Y., MARUCHI, N., & Totsuka, K. (2001) · Clinical Infectious Diseases · doi:10.1086/320147 · Cited by 52
An Exfoliative Toxin A‐Converting Phage Isolated from Staphylococcus aureus Strain ZM
YOSHIZAWA, Y., Sakurada, J., Sakurai, S., Machida, K., Kondo, I., & Masuda, S. (2000) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2000.tb02481.x · Cited by 35
Matsuzaki, S., Inoue, T., & Tanaka, S. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90607-p · Cited by 13
Self-citation
Cited by
Wittebole, X., De Roock, S., & Opal, S. M. (2014) · Virulence · doi:10.4161/viru.25991 · Cited by 599
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Population and evolutionary dynamics of phage therapy
Levin, B. R., & Bull, J. J. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro822 · Cited by 511
Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey
Deresinski, S. (2005) · Clinical Infectious Diseases · doi:10.1086/427701 · Cited by 466
Phage Choice, Isolation, and Preparation for Phage Therapy
Gill, J., & Hyman, P. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725311 · Cited by 441
Metadata
- Authors
- Matsuzaki, S., Yasuda, M., Nishikawa, H., Kuroda, M., Ujihara, T., Shuin, T., Shen, Y., Jin, Z., Fujimoto, S., Nasimuzzaman, M. D., Wakiguchi, H., Sugihara, S., Sugiura, T., Koda, S., Muraoka, A., & Imai, S.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02-15
- Volume
- 187
- Issue
- 4
- Pages
- 613-624
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2103527334
- Cited by
- 260
- References
- 31
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.